Association of liver metastases (LM) with survival in NSCLC patients treated with durvalumab (D) in two independent clinical trials Meeting Abstract


Authors: Paz-Ares, L. G.; Shen, K.; Higgs, B. W.; Morehouse, C.; Rizvi, N. A.; Segal, N. H.; Jin, X.; Zheng, Y.; Narwal, R.; Gupta, A. K.; Dennis, P. A.; Mukhopadhyay, P.; Ranade, K.
Abstract Title: Association of liver metastases (LM) with survival in NSCLC patients treated with durvalumab (D) in two independent clinical trials
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 147s
Language: English
ACCESSION: WOS:000411895705168
DOI: 10.1200/JCO.2017.35.15_suppl.3038
PROVIDER: wos
Notes: Meeting Abstract: 3038 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neil Howard Segal
    209 Segal
  2. Naiyer A Rizvi
    166 Rizvi